000			02783cam a2200361 4500
020			_a9241207647
035			_a(Sirsi) 9241207647
060			_aWC 220
111	2		_aWHO Study Group on Rheumatic Fever/Rheumatic Heart Disease.
242	1	0	_aRhumatisme articulaire aigu et cardiopathies rhumatismales : _brapport d' un Groupe d' étude de l' OMS [réuni à Genève du 30 mars au 4 avril 1987]
242	1	0	_aFiebre reumática y cardiopatía reumática : _binforme de un Grupo de Estudio de la OMS [se reunió en Ginebra del 30 de marzo al 4 de abril de 1987]
245	0	0	_aRheumatic fever and rheumatic heart disease : _breport of a WHO study group [meeting held in Geneva from 30 March to 4 April 1987]
260			_aGeneva : _bWorld Health Organization, _c1988.
300			_a58 p.
440		0	_aWorld Health Organization technical report series ; _vno. 764
500			_aita published by: Milan : McGraw-Hill Libri Italia.
500			_avie published by: Hanoi : Viet Nam National Heart Institute.
520	3		_aA review of the current state of knowledge and medical and public health practice with regard to group A streptococcal infections, rheumatic fever, and rheumatic heart disease and the advances that have occurred over the past twenty years. Recommendations are made for improving implementation of rheumatic fever control programmes, and on areas where specific basic and applied research is needed to control this problem more effectively. Of particular practical value is a section devoted to prevention, which offers detailed guidance on recommended antibiotic regimens for primary and secondary prophylaxis, including recommended drug, mode of administration, dose, and duration of treatment. Prospects for the development of a suitable vaccine are also briefly considered. Other sections discuss the requirements for prevention programmes at the community level, outline methods for diagnosis in the microbiology laboratory, and present recommended clinical procedures for diagnosis and management. In view of the importance of preventing infective endocarditis in patients with rheumatic valvular heart disease, the book also recommends treatment schedules for prophylaxis during dental, respiratory, gastrointestinal and genitourinary tract procedures.
546			_achi eng fre rus spa.
546			_aita per tur vie.
550			_aWHODOC
561			_aWHO monograph
596			_a4
650	0	2	_aRheumatic fever.
650	0	2	_aRheumatic heart disease.
690			_aNoncommunicable Diseases.
710	2		_aWorld Health Organization.
856			_uhttps://apps.who.int/iris/
856			_uhttps://apps.who.int/iris/
856			_uhttps://apps.who.int/iris/
008			880411s1988 eng
942			_2NLM _cMONOGRAPH
999			_c13921 _d13921